Pfizer/BioNTech Target Fall 2020 for COVID-19 Vaccine Availability

Vaccine maker Pfizer and German pharmaceutical BioNTech will have a COVID-19 vaccine ready to go “in the millions” by the end of 2020, according to a press release. The two companies are already in Phase 1 and Phase 2 clinical trials — with a grand total of 12 volunteers. The companies said they will enter a 200-subject trial soon, of people ages 18 to 55. When asked about the lightning speed at which the vaccines are being developed, National Vaccine Information Center...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports